FDA to change warnings, indications for certain opioid pain medications

New drug labeling standards issued Tuesday by the FDA urge prescribers to use increased caution with long-acting and extended-release opioid painkillers. A boxed warning will highlight risks of use while pregnant, and new language will indicate the drugs should be reserved for severe pain. The steps are intended "to combat the crisis of misuse, abuse, addiction, overdose and death from these potent drugs that have harmed too many patients and devastated too many families and communities," FDA Commissioner Dr. Margaret Hamburg said.

View Full Article in:

New York Times (tiered subscription model), The · Wall Street Journal (tiered subscription model), The · Los Angeles Times (tiered subscription model) · Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI